Abstract
Ublituximab Efficacy in Treatment-Naive Participants With Relapsing Multiple Sclerosis in the Phase 3 ULTIMATE I and II Studies (P6-3.015)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have